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A Genomewide Screen for Autism: Strong Evidence for Linkage
to Chromosomes 2q, 7q, and 16p
International Molecular Genetic Study of Autism Consortium (IMGSAC)*
Autism is characterized by impairments in reciprocal communication and social interaction and by repetitive and
stereotyped patterns of activities and interests. Evidence for a strong underlying genetic predisposition comes from
twin and family studies, although susceptibility genes have not yet been identified. A whole-genome screen for
linkage, using 83 sib pairs with autism, has been completed, and 119 markers have been genotyped in 13 candidate
regions in a further 69 sib pairs. The addition of new families and markers provides further support for previous
reports of linkages on chromosomes 7q and 16p. Two new regions of linkage have also been identified on chro-
mosomes 2q and 17q. The most significant finding was a multipoint maximum LOD score (MLS) of 3.74 at marker
D2S2188 on chromosome 2; this MLS increased to 4.80 when only sib pairs fulfilling strict diagnostic criteria were
included. The susceptibility region on chromosome 7 was the next most significant, generating a multipoint MLS
of 3.20 at marker D7S477. Chromosome 16 generated amultipointMLS of 2.93 at D16S3102, whereas chromosome
17 generated a multipoint MLS of 2.34 at HTTINT2. With the addition of new families, there was no increased
allele sharing at a number of other loci originally showing some evidence of linkage. These results support the
continuing collection of multiplex sib-pair families to identify autism-susceptibility genes.
Introduction
Autism (MIM 209850) is a neurodevelopmental disor-
der that affects at least 5 in 10,000 individuals (Fom-
bonne 1999). Onset is in the first 3 years of life, and the
core deficits comprise qualitative impairments in recip-
rocal communication and social interaction, as well as
repetitive and stereotyped behaviors and interests. Au-
tism is the prototypical pervasive developmental disor-
der (PDD); the PDDs are a group of related disorders
that includes atypical autism, Asperger syndrome, and
“pervasive developmental disorder not otherwise spec-
ified” (PDD NOS). The rate of autism amongst siblings
of singleton probands is higher, at ∼3%, than that in
the general population; the rate is further elevated when
other PDDs are included (Bailey et al. 1998; Szatmari
et al. 1998). In three same-sex twin studies, concordance
for autism in MZ pairs varied between 36% and 91%,
compared with 0% in DZ pairs (Folstein and Rutter
1977; Steffenburg 1991; Bailey et al. 1995), leading to
an estimated heritability of 190% (Bailey et al. 1995).
Received April 30, 2001; accepted for publication July 11, 2001;
electronically published July 30, 2001.
Addresses for correspondence and reprints: Dr. A. P. Monaco, Well-
come Trust Centre for Human Genetics, University of Oxford, Roo-
sevelt Drive, Oxford OX3 7BN, United Kingdom. E-mail: anthony
.monaco@well.ox.ac.uk. Dr. A. J. Bailey, Centre for Social, Genetic
and Developmental Psychiatry, Institute of Psychiatry, De Crespigny
Park, London SE5 8AF, United Kingdom. E-mail: anthony.bailey
@iop.kcl.ac.uk
* See Acknowledgments for a list of members.
 2001 by The American Society of Human Genetics. All rights reserved.
0002-9297/2001/6903-0010$02.00
Two twin studies (Folstein and Rutter 1977; Bailey et
al. 1995) have also found that the behavioral phenotype
extends beyond autism and other PDDs to include re-
lated, but milder, abnormalities in social behavior and
language, a finding replicated in family studies (Bailey
et al. 1998; Szatmari et al. 1998; Pickles et al. 2000).
The sibling recurrence risks and twin concordance find-
ings are incompatible with a Mendelian mode of inher-
itance, and statistical modeling suggests that 3 or 4 loci
are probably implicated, although as many as 15 loci
may be involved (Pickles et al. 1995).
The high concordance rates in MZ twins for autism
and the broader phenotype (Folstein and Rutter 1977;
Bailey et al. 1995) implicate genetic influences in the
vast majority of idiopathic cases. As yet, however, there
is no consensus about the neuropathological and neu-
rophysiological basis of autism, and, thus, there are no
very strong candidate genes. Autism is associated with
recognized medical disorders in a small minority of
cases, and these associations might indicate genes that
are potentially of wider significance. The strongest spe-
cific associations are with fragile-X syndrome and tu-
berous sclerosis. Hallmayer et al. (1994) found no ev-
idence that the fragile-X locus is implicated in idiopathic
cases. Similarly there is no evidence that previously un-
detected tuberous sclerosis accounts for a significant
proportion of cases, although TSC1 and TSC2 cannot
yet be excluded as possible susceptibility loci (Smalley
1998; Mbarek et al. 1999). A wide range of chromo-
somal abnormalities are found in up to 5% of cases of
autism (Gillberg 1998), the most consistent association
being with 15q11-q13 interstitial duplications or a su-
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pernumerary pseudodicentric chromosome 15 (inv-
dup[15]) that overlaps the Prader-Willi Angelman crit-
ical region (PWACR) of proximal 15q (see Lamb et al.
[2000] for a review).
Some 75% of individuals with autism are male, rais-
ing the possibility that genes on the X chromosome
might also be implicated in susceptibility. Hallmayer et
al. found modest evidence of linkage for autism on the
X chromosome (Hallmayer et al. 1996), with a maxi-
mum LOD score (MLS) of 1.24 at DXS424 on Xq24.
Philippe et al. (1999) also reported a two-point MLS
of 0.89 at DXS996 on Xp22.3. Skuse has suggested that
there may be a protective imprinted locus on the X
chromosome (Skuse 2000), although a higher threshold
for phenotypic expression in females could also explain
the observed sex ratio. Reports of excess paternal trans-
missions on chromosome 7 and maternal/paternal dif-
ferences in sharing on chromosome 15 have also led to
speculation that there may be a parent-of-origin effect
(Ashley-Koch et al. 1999, 2000; Sutcliffe and CLSA
2000).
The paucity of functional and positional candidate
genes for autism has led most research groups to follow
a strategy of a genomewide screen for linkage using
affected relative–pair families, followed by a positional
candidate-gene approach. The published genome
screens have found preliminary convergent evidence for
linkage in several genomic regions (for reviews, see
Lamb et al. [2000] and Turner et al. [2000]), with a
region on chromosome 7q showing increased allele
sharing in all screens. Nevertheless, the largest genome
screen to date (Risch et al. 1999), which analyzed 97
independent affected sib pairs with 519 microsatellite
markers and an additional 50 sib pairs with a subset of
149 markers in candidate regions, failed to generate a
LOD score with genomewide significance. This study
did, however, provide modest support for loci on chro-
mosomes 7 and 17, with a multipoint MLS of 0.93 at
D7S1804 and 1.21 at D17S1584.
Some evidence for linkage has also been found in the
Prader-Willi–Angelman critical region (PWACR) on
chromosome 15 (Bass et al. 2000), with a multipoint
MLS of 1.31 at D15S217. The g aminobutyric acid
receptor subunit b 3 (GABRB3) in this region has been
studied by several groups, but the findings are not con-
sistent (Cook et al. 1998; Maestrini et al. 1999; Salmon
et al. 1999; Martin et al. 2000). Sequencing of E6-AP
ubiquitin-protein ligase (UBE3A), which is also located
in cytogenetic band 15q11-13, has not detected func-
tional mutations (Veenstra-VanderWeele et al. 1999).
Studies of the serotonin transporter as a candidate gene
for autism have also proved inconclusive, with associ-
ation found in different populations with both the long
and short variant of an insertion/deletion polymorphism
(Cook et al. 1997; Klauck et al. 1997; Persico et al.
2000; Vicente et al. 2000), as well as with neither var-
iant (Maestrini et al. 1999; Zhong et al. 1999).
Elsewhere (IMGSAC 1998), we have reported anal-
ysis of 354 markers typed in 39 multiplex families and
a subset of 175 markers typed in 99 families. Here, we
present a complete genome screen for 83 sib pairs from
the original 99 families (IMGSAC 1998), using 349
markers, and the results of genotyping at 13 putative
susceptibility loci where linkage was indicated from the
completed genome screen. A subset of 74 markers used
in the original genome screen and 45 new markers have
now been genotyped in a total of 152 sib pairs. The
data have also been analyzed for evidence of linkage




The identification of families and the assessmentmeth-
ods used by the IMGSAC has been described in detail
elsewhere (IMGSAC 1998). In brief, in families passing
an initial screen, parents were given the Autism Diag-
nostic Interview-Revised (ADI-R) (Lord et al. 1994) and
the Vineland Adaptive Behavior Scales (Sparrow et al.
1984). Potential cases, who were all 4 years old, were
also assessed using either the Autism Diagnostic Obser-
vation Schedule (ADOS) (Lord et al. 1994) or ADOS-
Generic (ADOS-G) (Lord et al. 2000). When possible,
psychometric evaluation was conducted using Raven’s
progressive matrices (Raven 1989) or the Mullen Scales
of Early Learning (Mullen 1995), and the British Picture
Vocabulary Scale (Dunn et al. 1982) or the Peabody
Picture Vocabulary Test III (Dunn and Dunn 1997) or
an appropriate translation; other tests were administered
if clinically indicated. A history of language delay was
defined as no single words before age 24 mo and/or no
phrase speech before age 33 mo. Individuals who lost
language that was not regained by these ages were also
considered to have language delay. Individuals were as-
signed case status in a hierarchical fashion: they were
designated as “case type 1” if they had a clinical diag-
nosis of autism, met ADI-R (Lord et al. 1994) and ADOS
(Lord et al. 1994) or ADOS-G (Lord et al. 2000) al-
gorithm criteria for autism, and had a history of lan-
guage delay and a performance IQ of 35. Individuals
were designated as “case type 2” if they had a clinical
diagnosis of autism, atypical autism, Asperger syn-
drome, or PDD NOS and met at least ADOS-G criteria
for PDD; there was no requirement for a history of lan-
guage delay, and individuals were allowed to fall one
point below threshold on one behavioral domain of the
ADI-R. Case type 2 was subdivided into case type 2a
individuals, who had a performance IQ of 35 (np
572 Am. J. Hum. Genet. 69:570–581, 2001
Table 1
Criteria Used to Distinguish between Different Autism Case Types
Case
Type Criteria
1 Clinical diagnosis of autism, meets ADI-R
and ADOS or ADOS-G criteria for au-
tism, history of language delay, and per-
formance IQ of 35
2: Clinical diagnosis of autism, atypical autism,
Asperger syndrome or PDDNOS; score on
one ADI-R behavioral domain can be 1
point below threshold; meets at least
ADOS-G criteria for PDD; no requirement
of a history of language delay
2a Performance IQ of 35
2b No requirement of a performance IQ of 35
3 Clinical diagnosis of autism, atypical autism,
Asperger syndrome or PDDNOS; score on
one ADI-R behavioral domain can be one
point below threshold; fails to meet
ADOS-G criteria for PDD; performance
IQ of 35
), and case type 2b individuals, who had a perform-97
ance IQ either measured at or inferred to be !35 (np
). Individuals were designated as “case type 3” if they35
had a clinical diagnosis of autism or another PDD and
either met ADI-R criteria for autism or fell one point
below threshold in one behavioral domain but failed to
meet ADOS-G criteria for PDD. The criteria for each of
these case types are listed in table 1. These diagnostic
criteria differ from those described in previous work
published by IMGSAC (2001), since low-functioning in-
dividuals for whom an IQ could not be computed have
now been classified as case type 2b rather than case type
3. Also, case type 3 individuals have been described else-
where (IMGSAC 2001) as meeting ADI-R algorithm cri-
teria in all domains, whereas, like case type 2 individuals,
they can fall one point below threshold in one domain
only. The mean performance IQ for case type 1 individ-
uals was 79, for case type 2 individuals 82 (98 for in-
dividuals with case type 2a and 27 for individuals with
case type 2b; IQ could not be computed for six individ-
uals with case type 2b), and for case type 3 individuals
97. A detailed phenotypic description of the subjects
included in this study is in preparation.
Family Collection
Families have been collected and genotyped in four
successive stages. Increased stringency of inclusion cri-
teria has led to the current exclusion of nine families
included in the original screen. Of these, eight families
were excluded either because, so far, only the 1989 ver-
sion of the ADOS had been administered to nonverbal
individuals (for whom no algorithm exists) or because
it has not been possible to compute valid scores on psy-
chometric tests because of poor cooperation. The re-
maining family was excluded because of an abnormal
karyotype result. Of the original 99 extended families,
11 are not included in this analysis, which examines only
sib pairs. Eighty-three sib pairs from the 99 families pub-
lished elsewhere are now included. Through subsequent
family collection and assessment, 69 new sib pairs have
been recruited. In total there are now 152 affected sib
pairs, including three trios. Affected pairs were distrib-
uted in the following case type combinations: type 1/
type 1, 43 pairs; type 1/type 2, 84 pairs; type 2/type 2,
16 pairs; type 1/type 3, 7 pairs; and type 2/type 3, 2
pairs. The sex ratio (male:female) of all affected relative
pairs in the study sample was 4.8:1. There is no known
overlap between the families included in this study and
those ascertained by other research groups.
A physical examination was undertaken to exclude
recognizable medical causes of autism, particularly tu-
berous sclerosis. A blood sample for DNA extraction
was taken, when possible, from all cases and available
first-degree relatives. In addition, lymphoblastoid cell
lines were generated from peripheral blood leukocytes,
to ensure a renewable source of DNA. In cases in which
a blood sample could not be obtained, buccal swabs
were taken (7.2% of DNA samples). When possible,
karyotyping was performed—or previous results ob-
tained—on all affected individuals, and molecular ge-
netic testing for fragile-X syndrome was performed—or
previous results obtained—on one affected individual
from each family. Karyotype abnormalities were ex-
cluded in at least one affected individual in each family
in 94% of families and in both affected individuals in
86% of families. Fragile-X syndrome was excluded in
at least one affected individual in all 152 sib pairs. Writ-
ten informed consent was given by all parents/guardians
and, where possible, by affected individuals. The study
has been reviewed by the relevant ethical committees.
Genotyping
Genomic DNA was extracted and primer extension
preamplification performed as described elsewhere
(IMGSAC 1998). Genotyping was performed using a
semiautomated fluorescence-based method (Reed et al.
1994). PCR was performed in a 15-ml volume in 96-well
plates, containing 5 ml of 40 ng genomic DNA, 10 mM
Tris pH 8.3, 50 mM KCl, 1–3 mM MgCl2, 200 mM
dNTPs, 0.2 mM of each fluorescent primer, and 0.25 U
Taq or Taq Gold polymerase. The PCR consisted of 35
cycles of 30 s at 94C, 30 s at 45C–66C, and 30 s at
72C and was performed inMJ ResearchThermocyclers.
When Taq Gold was used, the program began with 15
min at 94C and finished with 7 min at 72C. PCR prod-
ucts were combined into pools and typed using ABI 373,
377, and 3700 sequencing machines and GENESCAN/
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GENOTYPER software (Applied Biosystems). Tamra
and Rox were used as internal lane-size standards, and
fluorescent markers were labeled with either HEX, TET,
NED, or FAM. Allele designation was performed with-
out knowledge of the individual’s status. A check for
non-Mendelian inheritance of markers and conversion
of allele sizes to whole numbers was performed using
GAS (version 2). Global binning was performed for
markers run on different types of sequencing machines,
using allele sizes generated from two positive control
DNA samples. Genotypic data was initially stored in
Genbase (version 2.0.5) and later was transferred to Dis-
covery Manager 2.3 (Genomica), along with phenotypic
data. All data for statistical analysis were exported from
Discovery Manager.
Genetic Markers
392 microsatellites and 2 single-nucleotide polymor-
phisms were typed in 83 sib pairs and a subset of 119
markers typed in a total of 152 sib pairs in the 13 can-
didate regions. The microsatellites include di-, tri-, and
tetranucleotide repeats and were taken from a variety of
sources, including Ge´ne´thon (Dib et al. 1996), ABI
PRISM Linkage Mapping Sets (Perkin-Elmer), The Co-
operative Human Linkage Centre (Murray et al. 1994),
the Genome Database, and Kwiatkowski et al. (1992).
A 5-cM map with 25 markers is used throughout this
article to refer to chromosome 7. Further genotyping
and analyses have been performed on the region of in-
terest on chromosome 7 (IMGSAC 2001) and are not
repeated here. The average intermarker distance for the
completed genome screen on 83 sib pairs was 9.92 cM.
In the 13 regions where further genotyping was done
on a total of 152 sib pairs, the average intermarker dis-
tance was reduced to one marker every 4.88 cM. Five
microsatellites were deleted from those used in the orig-
inal publication because of low informativeness.
Genetic marker order and map distances were taken
from Ge´ne´thon (Dib et al. 1996) and other published
maps (Murrell et al. 1995; Gilbert et al. 2000). These
were confirmed by running sib_map, part of the ASPEX
package.
Error Checking
Prior to statistical analysis, SIBMED (sib-pair muta-
tion error detection) was run on all data from the au-
tosomes to remove possible genotyping errors (Douglas
et al. 2000). A prescribed false-positive rate of !.001
was set given a prior genotyping-error rate of .01. After
the removal of identified genotyping errors, the data
were analyzed using the ASPEX statistical package. It
should be noted that SIBMED is most effective at elim-
inating errors in regions where marker density is 11
marker every 5 cM; this requirement was met for regions
on chromosomes 2 and 16, where marker density is ∼1
marker every 2 cM. The number of errors identified by
SIBMED was small compared to those in other pub-
lished work (Lathrop et al. 1983). This was due, in part,
to the high percentage of sib pairs with parental geno-
types available, 190% of families. All the MLSs quoted
were generated subsequent to data checking by
SIBMED.
Statistical Analysis
The data were prepared using Mega2 (Mukhopa-
dhyay et al. 1999) and were analyzed using the ASPEX
package to compute multipoint LOD scores. Despite the
high proportion of parental genotypes available,
sib_phase was used, rather than sib_ibd, to maximize
the amount of information available. Analyses were per-
formed using case status definitions to divide the sample
into three groups: type 1/type 1 pairs ( ), type 1/Np 43
type 2 pairs ( ), and all strict criteria pairs (typeNp 84
1/type 1  type 1/type 2 pairs) ( ). Case typesNp 127
2a and 2b were not analyzed separately, because of small
sample sizes. Paternal and maternal transmission was
analyzed using sib_ibd with the sex_split option, to elu-
cidate the number of transmissions of maternal and pa-
ternal alleles contributing to sharing for each marker.
The transmission/disequilibrium test (TDT) (Spielman
et al. 1993) was also performed, using sib_tdt on mark-
ers beneath peaks of linkage. Empirical P values for x2
statistics were calculated to test for association indepen-
dent of linkage (multiple sibs were used per family dur-
ing analysis of the data for linkage).
To assess data quality and support the multipoint
analysis, SPLINK was used to calculate single-point
MLSs, under “possible triangle” restrictions, by esti-
mating the probability of affected sibs sharing 0, 1, or
2 alleles identical by descent (IBD) (Holmans 1993; Hol-
mans and Clayton 1995). Both SPLINK and ASPEX use
maximum-likelihood methods to estimate marker allele
frequencies within the database. ASPEXmultipoint anal-
ysis was performed under an additive model (no dom-
inance variance), so that if is the probability of anzi
affected sib pair sharing i alleles identical by descent,
then , , and , wherez p .25/l z p .5 z p .50 z l0 s 1 2 0 s
is defined as the sibling recurrence risk.
Results
Multipoint Linkage Analysis
The results of the multipoint linkage analysis of the
83 sib pairs from the IMGSAC (1998) screen indicated
12 chromosomes with regions showing an MLS 10.82
(chromosomes 1, 2, 4, 7, 8, 9, 10, 14, 16, 17, 19, and
22). Chromosome 7 had the highest multipoint MLS in
the initial screen (IMGSAC 1998), and further analysis
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Table 2
Single-Point MLS Determined by SPLINK and Multipoint MLS Generated by ASPEX, for the 13
Chromosomes Genotyped in 152 Sib Pairs
MARKER cMa
SINGLE-POINT MLS MULTIPOINT MLS
All ESSb Oldc (83) All (152) 1/1d (43) 1/2e (84) Strictf (127)
D1S218 225.21 .64 81.22 [.57] .58 .00 .97 .68
D1S249 255.59 .65 120.48 .30 .60 .21 .16 .35
D2S131 24.31 .16 58.10 .22 .39 1.97 .00 .09
D2S1351 111.43 2.52 87.33 .71 1.60 .68 1.17 1.22
D2S2188 206.39 3.59 85.94 [.44] 3.74 1.24 3.66 4.80
D4S2936 .00 1.58 98.58 1.31 .71 .48 .03 .31
D4S430 140.57 .42 53.85 .37 .44 .05 .61 .59
D4S408 230.15 .02 22.93 .04 .43 1.04 .00 .75
D7S477 119.60 2.93 70.95 [1.18] 3.20 .00 3.55 2.33
D8S552 29.21 .28 65.88 .04 .49 .47 .22 .58
D8S261 38.84 .30 73.97 .65 1.12 .16 .77 .90
D8S1786 48.37 .67 97.73 .23 .19 .00 .24 .02
D9S157 18.93 .79 85.41 [.00] .75 .00 3.11 2.02
D9S164 140.25 .96 79.29 .20 1.09 .59 1.31 1.90
D9S1826 141.87 1.83 38.13 [.24] 1.46 .06 3.59 2.23
D9S158 142.07 2.97 33.65 .23 1.36 .00 3.16 2.09
D10S197 53.66 .65 74.66 .91 1.08 .75 .59 1.26
D10S208 64.29 1.38 90.72 [.72] 1.43 .11 .98 1.00
D10S201 116.63 1.37 105.99 .60 1.22 .47 .17 .56
D14S80 19.70 1.13 92.94 .64 .33 .02 .37 .34
D14S1034 24.62 .89 93.08 .78 .41 .05 .44 .46
D14S68 90.45 .14 61.52 .06 .07 .00 .67 .34
D14S267 119.65 .50 73.03 .92 .99 .00 1.07 .51
D15S129 34.10 .30 86.84 .02 .76 1.47 .44 1.49
CYP19g 40.46 .60 42.54 .12 .65 2.21 .14 1.20
D16S407 16.70 2.19 107.61 1.26 1.59 .14 2.22 2.11
D16S3114 21.80 2.52 114.61 1.11 2.12 .36 2.05 1.81
D16S3102 23.10 .78 49.07 .96 2.93 .49 2.20 2.61
D17S786 7.60 .47 49.99 .18 .80 .00 1.63 .92
HTTINT2h 45.37 3.60 37.75 .14 2.34 .61 1.27 1.87
D17S250 53.68 1.77 105.54 .09 1.60 .51 .57 1.04
D19S220 63.02 1.11 105.24 .18 .13 .03 .07 .10
CYP2Di 41.43 .82 41.17 .39 .33 .00 1.22 .25
NOTE.—Markers with the highest single-point and multipointMLSs are shown, includingmarkerswhere
the highest multipoint MLS was generated when the data were divided by case type status. Underlined
markers and figures indicate that an MLS 13 was generated. Numbers in parentheses indicate the number
of sib-pairs analyzed.
a cM p approximate distance, in Haldane centimorgans, from pter to marker.
b ESS p effective sample size, as calculated by SPLINK.
c Old p previously published genotype data analyzed with 83 original sib pairs included. Numbers in
square brackets indicate MLS at new marker position.
d 1/1 p case type 1/type 1 pairs.
e 1/2 p case type 1/type 2 pairs.
f Strict p case type 1/type 1 pairs  type 1/type 2 pairs.
g CYP19 is on chromosome 15.
h HTTINT2 is on chromosome 17.
i CYP2D is on chromosome 22.
using this enlarged data set has recently been reported
(IMGSAC 2001). The remaining 11 chromosomal areas
had multipoint MLSs between 0.82 and 2.05 and a sup-
porting single-point MLS. Further genotyping was also
performed on chromosome 15, because of previous re-
ports of linkage and chromosomal abnormalities asso-
ciated with autism (Gillberg 1998). Table 2 presents re-
sults for these 12 chromosomes in the enlarged sample
of 152 sib pairs at loci where either the SPLINK single-
point MLS or the ASPEX multipoint MLS were highest,
as well as for chromosome 15. The results from the 83
sib pairs currently included from the initial screen
(IMGSAC 1998) are also shown for comparison. The
mean effective sample size for each marker across the
genome was 59.2, and the estimated average marker
heterozygosity was .74.
The results from ASPEX analysis for all 152 sib pairs
after the removal of errors identified by SIBMED are
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Figure 1 Multipoint maps across all chromosomes, from pter to qter, generated by ASPEX under an additive model with no dominance
variance. The position of markers attaining a maximum MLS 11.5 are shown as triangles and have been typed in 152 sib pairs.
shown in figure 1. SIBMED identified 232 genotypes for
removal from a total of 308,450 genotypes, giving an
error rate of .075%. None of the reported peak MLSs
were increased by 10.28 by the removal of potential
genotyping errors.
In the total sample of 152 sib pairs, an ASPEX mul-
tipoint MLS 13 was generated on two chromosomes,
the highest being an MLS of 3.74 on the long arm of
chromosome 2 at D2S2188; this finding was supported
by a SPLINK single-point MLS of 3.59. Chromosome
7 provided an MLS of 3.20 at D7S477, supported by a
single-point MLS of 2.93. The third-highest multipoint
MLS, 2.93, was on the short arm of chromosome 16 at
D16S3102. A SPLINK single-point MLS of 2.97 and a
multipoint MLS of 1.36 were generated at D9S158 on
chromosome 9. However, the low effective sample size
(33.73) at this locus and the telomeric location should
be taken into account when considering the significance
of this result. Four chromosomes (2, 7, 16, and 17) gen-
erated a multipoint MLS 11.5, whereas the previous ev-
idence of linkage on chromosomes 4, 14, 19, and 22
diminished.
Allelic Association
When the ASPEX multipoint MLS was 11.5, mul-
tiallelic TDTs were performed to test for association.
Thirty-three markers were tested, and no significant ev-
idence for association ( ) was found in theseP 1 .05
regions. Some evidence for association has been reported
elsewhere in the area of linkage on chromosome 7
(IMGSAC 2001).
Analysis of Data by Case Status
Grouping of affected individuals into specific case
types, as described in table 1, provides an opportunity
to analyze data hierarchically and, potentially, to min-
imize heterogeneity. Accordingly, multipoint analysis
was performed using ASPEX for specific case type com-
binations in regions genotyped in 152 sib pairs. Regions
where the analysis by case type status gave the highest
multipoint MLS are presented in table 2.
In general, the 43 case type 1/type 1 affected sib pairs
do not contribute strongly to multipoint MLS in the
regions studied. The exceptions were on chromosome
15 at CYP19, where the highest multipoint for case type
1/type 1 pairs was achieved with a multipoint MLS of
2.21, and on chromosome 2, at D2S188, where they
attained a multipoint MLS of 1.24.
The larger group of 84 type 1/type 2 pairs showed
considerably more sharing, and five chromosomes (2, 7,
9, 16, and 17) achieved a multipoint MLS 11.5. Com-
bining type 1/type 1 and type 1/type 2 pairs gives 127
strictly defined sib pairs, which, together, generated an
MLS 11.0 on seven chromosomes (2, 7, 9, 10, 15, 16,
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Figure 2 Multipoint maps generated in ASPEX for sib pairs analyzed by case type. The yellow line represents the multipoint MLS for
case type 1/type 1 pairs (43), the blue line represents type 1/type 2 pairs (84), and the red line represents strict criteria pairs (127). The black
line represents the total multipoint MLS for 152 sib pairs. Blue triangles represent markers typed in 83 sib pairs, and pink triangles represent
markers typed in 152 sib pairs. Distances are approximate, in haldane M, from pter to qter.
and 17); the highest MLS was 4.80 on chromosome 2
at D2S2188. Multipoint plots by case type are shown
for chromosomes 2, 9, 10, 15, 16, and 17 in figure 2.
Paternal and Maternal Allele Transmission
Sex-specific analysis on chromosomes 2, 9, 10, 15, 16,
and 17 was carried out using ASPEX to calculate sep-
arate LOD scores for paternal and maternal sharing.
There was substantial variation in the contribution of
paternal and maternal sharing to the multipoint MLS
across these six chromosomes. On chromosomes 2 and
15, paternal and maternal sharing was approximately
equal. At D2S2188, paternal- and maternal-specificmul-
tipoint LODs were 2.10 and 1.95, respectively, and, at
D15S129, paternal- and maternal-specific multipoint
LODs were 0.45 and 0.32, respectively. There was some
evidence for an increased paternal contribution to the
multipoint MLS for chromosomes 16 and 17 at
D16S3102 and HTTINT2, with paternal multipoint
LODs of 2.21 and 2.32, compared with maternal mul-
tipoint LODs of 0.96 and 0.16, respectively. Conversely,
on chromosomes 9 and 10, at D9S157 and D10S208,
there was evidence that all sharing at these loci was
maternally derived, with paternal multipoint LODs of
0 and maternal multipoint LODs of 1.43 and 0.75,
respectively.
To evaluate the significance of the maternal and pa-
ternal sharing differences, single-point calculations were
also performed; of 34 markers tested, only 2 supported
the multipoint analysis ( ). The increasedmaternalP ! .05
sharing at D10S208 was supported with 62/92 maternal
transmissions, compared with 40/82 paternal transmis-
sions, giving a P value of .0196. Significantly increased
paternal sharing was found at D17S798, 1.8 cM distal
to HTTINT2, with 62/92 paternal transmissions, com-
pared with 44/95 maternal transmissions, giving a P
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value of .0058. Single-point analysis of flanking markers
at the above loci did not show significant differences in
parental sharing, indicating that these results may have
arisen by chance.
Discussion
The completion of a whole-genome screen for autism in
83 sib pairs indicated 12 regions with nominal evidence
for linkage. These regions were further characterized by
the addition of 69 new sib pairs who were genotyped
using a subset of 74 of the original markers and 45 new
markers. The effect of adding new sib pairs and markers
has been to reduce “noise” across the genome. Loci on
chromosomes 4, 19, and 22 previously reported as hav-
ing an ASPEX multipoint MLS 11 (IMGSAC 1998) now
all have a multipoint MLS !1. Among the 12 loci with
an MLS 10.82, genomewide significance—as defined by
Lander and Kruglyak (1995)—has been reached at one
locus on chromosome 2, with a multipoint MLS of 3.74
at D2S2188. Suggestive linkages have been found on
chromosomes 7, 16, and 17, with multipoint MLSs of
3.20, 2.93, and 2.34, respectively.
The chromosome 2 result is the highest multipoint
MLS generated to date in an autism genome screen; it
is supported by a reported nominal linkage of 0.64 by
Philippe et al. (1999) between markers D2S382 and
D2S364, which flank D2S2188, and by Buxbaum et al.
(2001), who found a maximum multipoint nonpara-
metric linkage score of 2.39 between D2S335 and
D2S364, also flanking D2S2188. When the subset of
127 sib-pair families identified using strict criteria was
considered, the multipoint MLS at D2S2188 increased
to 4.80. As described by Lamb et al. (2000), the chro-
mosome 7 linkage has also been replicated, although
location estimates vary. Our findings on chromosome
16 directly overlap those of Philippe et al. (1999), who
found a multipoint MLS of 0.74 between 23.3 and 39.0
cM. The modest MLS of 1.43 at D10S208 on chro-
mosome 10 should be viewed with caution, following
reports of transmission ratio distortion in CEPH pedi-
grees in this region (Paterson and Petronis 1999). In-
creasing the number of markers and sib pairs genotyped
in this region will help guard against any artificial in-
flation of LOD score (Greenwood and Morgan 2000).
It is unclear why case type 1/type 1 pairs contribute
so little to the strongest linkage findings. This group
may be more genetically heterogeneous than other com-
binations of case types (although it includes no severely
handicapped cases), or, perhaps, the presence of lan-
guage delay in both affected individuals identifies a
small specific subgroup of families. It may be relevant
that the 43 case type 1/type 1 pairs generated a mul-
tipoint MLS of 2.21 on chromosome 15 at CYP19. The
linkage on chromosome 15 extends to D15S129, which
had a multipoint MLS of 1.49 and is ∼25 cM distal
from the position of chromosomal abnormalities as-
sociated with autism. It is possible to interpret this find-
ing as supporting a susceptibility locus that is potentially
specific to severe autism with language delay.
Despite the width of the peaks of linkage and despite
evidence from simulation studies that there is large var-
iation in peak location relative to actual disease-gene
location (Roberts et al. 1999), a number of potential
candidate genes are worth noting briefly. On chromo-
some 2, two distalless homeobox genes (DLX1 and
DLX2) are located in 2q32 (Zerucha et al. 2000), and
their homologues (DLX5 and DLX6) are located in
7q22, beneath the second highest peak of linkage. An-
other gene of interest on chromosome 2 is alpha-1-chi-
maerin (a1CHIM) and the alternatively spliced
a2CHIM, a GTPase-activating protein. The rat ho-
mologue of a1CHIM and a2CHIM (n-chimaerin) has
mRNA expression restricted to neurons and is increased
during cellular differentiation and synaptogenesis (Lim
et al. 1992). Other interesting genes in the region include
t brain 1 (TBR1), neuropilin (NRP2), and cAMP re-
sponse element-binding protein 1 and 2 (CREB1 and
CREB2).
On chromosome 7q32, potential candidate genes in-
clude plexin (PLXNA4), which forms a complex with
neuropilin and mediates repulsion by the axonal guid-
ance signal semaphorin 3A (Rohm et al. 2000). The
imprinted genes PEG1/MEST (Hayashida et al. 2000)
and g2-COP (Blagitko et al. 1999) are also within the
candidate region on chromosome 7q32 and may be rel-
evant, given the possibility of a parent-of-origin–specific
effect in autism. Ashley-Koch has reported increased
paternal transmission in this region, and there was some
evidence to support this in our families (Ashley-Koch
et al. 2000; IMGSAC 2001). It may also be useful to
consider candidate genes in the 5.6-cM SPCH1 region
on 7q31 (Lai et al. 2000). Several recent studies suggest
Reelin (RELN) on 7q22 as a candidate gene for autism.
TDT analysis of a polymorphic trinucleotide repeat in
the 5′ UTR of Reelin has been reported to show pref-
erential transmission of a particular allele/alleles in au-
tistic probands (Zhang et al. 2000; Persico et al. 2001).
The locus with the third-highest MLS, generating a
multipoint MLS of 2.93, was on 16p13. An N-methyl-
D-aspartate receptor (NMDA) gene is located at
16p13.3, and this receptor plays an important role in
synaptic plasticity. The NMDA channel is formed by
two members of the glutamate receptor channel
(GluR)–subunit family and has been found to cause a
deficit in spatial learning in mutant mice when knocked
out (Sakimura et al. 1995). Other important loci in the
chromosome 16 region include tuberous sclerosis 2
(TSC2) (Burn et al. 1996); a gene for one of the netrins
(NTN2L), a family of chemotrophic factors that play a
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central role in axon guidance (Van Raay et al. 1997);
and the CREB-binding protein (CREBBP).
The significance of the reported parent-of-origin ef-
fect in autism is unclear from the analysis of our data.
We found no evidence to support claims for a significant
skew in IBD parental transmission of alleles on chro-
mosomes 7 and 15 (Ashley-Koch et al. 1999, 2000;
Sutcliffe and CLSA 2000) or for the peak on chromo-
some 2. There was, however, some evidence from the
multipoint MLS to support increased paternal-allelic
transmission on chromosomes 16 and 17, with the locus
on chromosome 17 supported by single-point analysis.
Maternal allele transmission was also increased in both
multipoint MLS and single-point analysis on chromo-
some 10. The lack of support for these results from
flanking marker single-point analysis indicates that they
may simply reflect chance observations.
These findings demonstrate the utility of enlarging
collections of affected relative–pair families, both in
terms of strengthening putative true linkages and in-
dicating which preliminary findings are likely to have
been false positives. Indeed, as yet, no group has at-
tained a sample size of 200 affected relative pairs, the
generally accepted minimum sample size for a whole
genome scan of complex diseases (Weeks and Lathrop
1995). The replication of findings on chromosomes 2,
7, and 16 across different groups—whose families are
drawn from somewhat different populations—is very
promising for the general applicability of the findings.
Efforts to establish a meta-analysis should further ad-
vance this process.
With regard to future work, there is a need to utilize
all the available genetic and phenotypic information in
nuclear families. This requires accurate description of
the affected status of relatives who do not have a PDD.
Eventually it may be possible, by means of QTL ap-
proaches, to combine data from affected individuals and
their relatives. Future work will also involve conditional
analysis to examine locus interaction (epistasis) and the
extent of heterogeneity in autism (Cox et al. 1999).
Careful consideration of potential candidate genes will
also be necessary to provide a biological basis for testing
the presence of interaction—for example, between the
DLX genes on chromosomes 2 and 7.
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